Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) Return on Assets (2022 - 2025)

Prime Medicine filings provide 4 years of Return on Assets readings, the most recent being 0.01% for Q4 2025.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Assets hit 0.01% in Q4 2025 for Prime Medicine, up from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2023 to a low of 0.01% in Q4 2023.
  • Median Return on Assets over the past 4 years was 0.01% (2025), compared with a mean of 0.01%.
  • The widest YoY moves for Return on Assets: up 0bps in 2023, down 0bps in 2023.
  • Prime Medicine's Return on Assets stood at 0.0% in 2022, then tumbled by -116bps to 0.01% in 2023, then soared by 32bps to 0.01% in 2024, then grew by 9bps to 0.01% in 2025.
  • The last three reported values for Return on Assets were 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025) per Business Quant data.